Literature DB >> 31258793

VASCULAR ENDOTHELIAL GROWTH FACTOR SERUM LEVELS IN WOMEN WITH ADVANCED ENDOMETRIOSIS.

A Malutan1, T Drugan2, C Georgescu3, R Ciortea1, C Bucuri1, A Bobric1, M P Rada1, D Mihu1.   

Abstract

CONTEXT: Endometriosis is a common gynecological disease, characterized by ectopic deposits of endometrial tissue outside of the uterine cavity, and it is associated with pelvic pain and infertility, with an important impact on the quality of life. At this point there is a controversy regarding the etiology and pathophysiology of endometriosis and it seems that pro-angiogenic growth factors might be involved, but their role is not completely understood.
OBJECTIVE: To evaluate the serum concentration of the main growth factors in patients with diagnosed endometriosis compared to healthy controls. SUBJECTS AND METHODS: A total of 157 women were divided into two study groups (Group I - endometriosis; Group 2 - healthy women). Serum levels of VEGF, G-CSF, GM-CSF, b-FGF, EGF, and HGF were measured with Human Multiplex Cytokine Panels.
RESULTS: VEGF serum levels were significantly lower in women with endometriosis compared to controls (1.924±0.145 compared to 1.806±0.078 pg/mL, p<0.001). Serum levels of GM-CSF, b-FGF, EGF, and HGF respectively did not differ significantly between patients with endometriosis and healthy controls. G-CSF had a very low detection rate.
CONCLUSIONS: The present study showed that VEGF serum levels are significantly lower in endometriosis patients compared to healthy controls, indicating a possible role in endometriosis pathogenesis.

Entities:  

Keywords:  endometriosis; growth factors; immunology; inflammation

Year:  2016        PMID: 31258793      PMCID: PMC6586760          DOI: 10.4183/aeb.2016.7

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  46 in total

Review 1.  Endometriosis.

Authors:  Linda C Giudice; Lee C Kao
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

Review 2.  Role of cytokines in endometriosis.

Authors:  T Harada; T Iwabe; N Terakawa
Journal:  Fertil Steril       Date:  2001-07       Impact factor: 7.329

Review 3.  Angiogenic factors in endometriosis.

Authors:  Robert N Taylor; Dan I Lebovic; Michael D Mueller
Journal:  Ann N Y Acad Sci       Date:  2002-03       Impact factor: 5.691

4.  Methodological concerns regarding levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis.

Authors:  Simone Ferrero; David John Gillott; Paola Anserini; Valentino Remorgida; Børge Teisner; Jurgis Gediminas Grudzinskas
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

5.  Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines.

Authors:  I M Matalliotakis; A G Goumenou; G E Koumantakis; M A Neonaki; E E Koumantakis; E Dionyssopoulou; I Athanassakis; S Vassiliadis
Journal:  Int Immunopharmacol       Date:  2003-01       Impact factor: 4.932

6.  Determination of HGF concentration in serum and peritoneal fluid in women with endometriosis.

Authors:  Li-li Zong; Ya-li Li; Xiao-qing Ha
Journal:  Di Yi Jun Yi Da Xue Xue Bao       Date:  2003-08

7.  Higher activity by opaque endometriotic lesions than nonopaque lesions.

Authors:  Khaleque Newaz Khan; Hideaki Masuzaki; Akira Fujishita; Michio Kitajima; Ichiro Sekine; Tadayuki Ishimaru
Journal:  Acta Obstet Gynecol Scand       Date:  2004-04       Impact factor: 3.636

8.  Concentrations of alpha-fetoprotein, insulin-like growth factor binding protein-3, c-erbB-2, and epidermal growth factor in serum of patients with endometriosis.

Authors:  Fabianne Philippoussis; Danièle Gagné; Patrice Hugo; Diane Gosselin
Journal:  J Soc Gynecol Investig       Date:  2004-04

9.  Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis.

Authors:  D Gagné; M Pagé; G Robitaille; P Hugo; D Gosselin
Journal:  Hum Reprod       Date:  2003-08       Impact factor: 6.918

Review 10.  Potential involvement of the immune system in the development of endometriosis.

Authors:  Cleophas M Kyama; Sophie Debrock; Jason M Mwenda; Thomas M D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2003-12-02       Impact factor: 5.211

View more
  4 in total

1.  FSH RECEPTOR AND FSH BETA CHAIN POLYMORPHISM INVOLVEMENT IN INFERTILITY AND ENDOMETRIOSIS DISEASE.

Authors:  A Tanase; D Nemescu; R Popescu; B F Toma; R D Matasariu; M Onofriescu
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Apr-Jun       Impact factor: 0.877

2.  Genetic polymorphisms of Vascular Endothelial Growth Factor (VEGF) associated with endometriosis in Nigerian women.

Authors:  Ochuwa Adiketu Babah; Oyesola Oyewole Ojewunmi; Akinniyi Adediran Osuntoki; Melissa A Simon; Bosede Bukola Afolabi
Journal:  Hum Genomics       Date:  2021-10-30       Impact factor: 4.639

3.  Expression levels of MCP-1, HGF, and IGF-1 in endometriotic patients compared with non-endometriotic controls.

Authors:  Sahel Heidari; Roya Kolahdouz-Mohammadi; Sepideh Khodaverdi; Nader Tajik; Ali-Akbar Delbandi
Journal:  BMC Womens Health       Date:  2021-12-20       Impact factor: 2.809

Review 4.  Abdominal wall endometriosis (a narrative review).

Authors:  Mara Carsote; Dana Cristiana Terzea; Ana Valea; Ancuta-Augustina Gheorghisan-Galateanu
Journal:  Int J Med Sci       Date:  2020-02-10       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.